Interferon-α Based Individualized Treatment of a High Risk Chronic Myelogenous Leukemia Patient Harboring T315I Mutation
2017 ◽
Vol 76
(6)
◽
pp. AB5
◽
2012 ◽
Vol 95
(2)
◽
pp. 209-213
◽
2009 ◽
Vol 45
(6)
◽
pp. 1113-1114
◽
2015 ◽
Vol 42
(3)
◽
pp. 338-339
◽